Wang L - Search Results

1

NUBE2R2-AS1 as Prognostic Marker, Promotes Cell Migration and Invasion in Non-Small Cell Lung Cancer by Modulating Epithelial-Mesenchymal Transition Process.

Liu X, Liao B, Wang L, Lu L, Yao W, Chen M. Liu X, et al. Among authors: wang l. Ann Clin Lab Sci. 2022 May;52(3):462-469. Ann Clin Lab Sci. 2022. PMID: 35777800

2

[Advances on effects of triptolide with non-small cell lung cancer].

Wang L, Song Y. Wang L, et al. Zhongguo Fei Ai Za Zhi. 2013 Jul;16(7):378-81. doi: 10.3779/j.issn.1009-3419.2013.07.09. Zhongguo Fei Ai Za Zhi. 2013. PMID: 23866670 Free PMC article. Review. Chinese.

3

Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.

Wang L, Qu J, Liang Y, Zhao D, Rehman FU, Qin K, Zhang X. Wang L, et al. Thorac Cancer. 2020 Apr;11(4):851-866. doi: 10.1111/1759-7714.13298. Epub 2020 Feb 14. Thorac Cancer. 2020. PMID: 32059076 Free PMC article.

4

Combined Radiomics-Clinical Model to Predict Radiotherapy Response in Inoperable Stage III and IV Non-Small-Cell Lung Cancer.

Chen W, Wang L, Hou Y, Li L, Chang L, Li Y, Xie K, Qiu L, Mao D, Li W, Xia Y. Chen W, et al. Among authors: wang l. Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221142400. doi: 10.1177/15330338221142400. Technol Cancer Res Treat. 2022. PMID: 36476110 Free PMC article.

5

Comparative Effectiveness of Pemetrexed-platinum Doublet Chemotherapy With or Without Bevacizumab as First-line Therapy for Treatment-naive Patients With Advanced Nonsquamous Non-small-cell Lung Cancer in China.

Li X, Abbas M, Li Y, Teng Y, Fang Y, Yu S, Wen Y, Wang L, Shi M. Li X, et al. Among authors: wang l. Clin Ther. 2019 Mar;41(3):518-529. doi: 10.1016/j.clinthera.2019.02.004. Epub 2019 Mar 4. Clin Ther. 2019. PMID: 30846285

6

Effect and biomarker of Nivolumab for non-small-cell lung cancer.

Wang L, Zhao D, Qin K, Rehman FU, Zhang X. Wang L, et al. Biomed Pharmacother. 2019 Sep;117:109199. doi: 10.1016/j.biopha.2019.109199. Epub 2019 Jul 5. Biomed Pharmacother. 2019. PMID: 31387181 Free article. Review.

7

Survival-associated alternative splicing signatures in non-small cell lung cancer.

Zhao D, Zhang C, Jiang M, Wang Y, Liang Y, Wang L, Qin K, Rehman FU, Zhang X. Zhao D, et al. Among authors: wang l, wang y. Aging (Albany NY). 2020 Apr 13;12(7):5878-5893. doi: 10.18632/aging.102983. Epub 2020 Apr 13. Aging (Albany NY). 2020. PMID: 32282333 Free PMC article.

8

The efficacy of postoperative radiotherapy for patients with non-small cell lung cancer: An updated systematic review and meta-analysis.

Wang Z, Yang B, Zhan P, Wang L, Wan B. Wang Z, et al. Among authors: wang l. J Cancer Res Ther. 2022 Dec;18(7):1910-1918. doi: 10.4103/jcrt.jcrt_167_22. J Cancer Res Ther. 2022. PMID: 36647949 Free article.

9

[Expression and significance of PTEN/PI3K signal transduction-related proteins in non-small cell lung cancer].

Liao DW, Wang L, Zhang XG, Liu MQ. Liao DW, et al. Among authors: wang l. Ai Zheng. 2006 Oct;25(10):1238-42. Ai Zheng. 2006. PMID: 17059767 Chinese.

10

Identification of MET fusions as novel therapeutic targets sensitive to MET inhibitors in lung cancer.

Sun D, Wu W, Wang L, Qu J, Han Q, Wang H, Song S, Liu N, Wang Y, Hou H. Sun D, et al. Among authors: wang h, wang l, wang y. J Transl Med. 2023 Feb 25;21(1):150. doi: 10.1186/s12967-023-03999-7. J Transl Med. 2023. PMID: 36829199 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147,880 results

Search Page

Filters